Letters to the Editor

Macauley V. , Smith I.E. Advanced breast cancer. In: Randomised trials in cancer: a critical review by sites. Slevin M.L. , Staquet M.J. eds New York: Raven Press, 1986

Powles T.J. , Smith I.E. , Ford H.T. Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet 1980; i: 580–2

Jain K.K. , Casper E.S. , Geller N.L. A prospective randomised comparison of Epirubicin and Doxorubicin in patients with advanced breast cancer. J Clin Oncol 1985; 3: 818–26

Brambilla C. , Rossi A. , Bonfante V. Phase II study of doxorubicin versus epirubicin in advanced breast cancer Cancer Treat Rep 1986; 70: 261–6

Jones W.G. Weekly low dose Epirubicin: effective single agent palliation for advanced breast cancer 4th EORTC breast cancer working conference, London, 1987

Hortobagyi G. , Blumenschein G. , Frye D. Doxorubicin versus 4'Epidoxorubicin for metastatic breast cancer: a prospective randomised study. Proc of Am Soc Clin Oncol 1984; 3: 121

Price L.A. , Hill B.T. Breast cancer trials - a new initiative. Br Med J 1981; 282: 563

Baum M. Breast cancer trials - a new initiative. Br Med J 1981; 282: 563–4

Levine M.N. , Gent M. , Hirsh J. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl Med J 1988; 318: 404–7

Henderson I.C. Adjuvant therapy for breast cancer. N Engl Med J 1988; 318: 443–4

Early breast cancer trialists. Adjuvant endocrine and cytotoxic therapy in early breast cancer: a systematic overview of all available randomised trials. N Engl J Med 1988; (in press)